- Home
- Investing
- Stocks
The Nasdaq Composite, with a little help from tech's friends, rises to within 300 points of its own new all-time high.
By
David Dittman
published
7 January 2026
in News
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
Share Share by:- Copy link
- X
All three main U.S. equity indexes opened in the green but struggled to hold gains during a mixed trading session on Wednesday. Still, the Dow Jones Industrial Average and the S&P 500 set new all-time intraday highs before slipping into the red, and the Nasdaq Composite is rising on breadth expansion and sector rotation.
One big name was a big winner and another big name was a big loser, but health care stocks still managed to join communication services and tech stocks in positive territory.
Consumer discretionary faded late, and energy stocks reflect a market still digesting President Donald Trump's major move to reestablish U.S. hegemony in the Western Hemisphere through an updated Monroe Doctrine focused on oil reserves purportedly held by Venezuela.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
CLICK FOR FREE ISSUE
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Sign upUtility stocks and materials were lower, too, after posting notable gains earlier in the week. Financial stocks retreated, as well, with sector leader JPMorgan Chase (JPM, -2.3%) among the notable names scheduled to report earnings next week.
The economic calendar is once more a source of timely government-collected data. This week, it's highlighted by the Friday 8:30 am Eastern Standard Time release of the December jobs report.
In the interim, the ADP National Employment Report showed private firms added 41,000 jobs last month. And the Job Openings and Labor Turnover Survey (JOLTS) from the Bureau of Labor Statistics indicated job openings, hires and separations were little changed in November.
Track all markets on TradingView"The labor market has cooled a little since the summer," observes Guy Berger, the workforce economist in residence at Guild, who notes that the unemployment rate has increased and hiring is a little lower than it was a few months ago. "But we don't have more precision than that," he adds. "It'd be nice to have more data to prove (or disprove) it. And on Friday, we're getting that data!"
By Wednesday's closing bell, the Dow Jones Industrial Average was off 0.9% to 48,996, despite reaching a fresh peak early in the session. The S&P 500, meanwhile, had shed 0.3% to 6,902, also setting another new all-time intraday high in the process.
The Nasdaq Composite held on for a 0.2% gain to 23,584, rising for a third straight session even as sectors other than tech continue to show some leadership.
UNH vs AMGN
UnitedHealth Group (UNH, -2.1%) was No. 25 among Dow Jones stocks today, even as No. 1 Amgen (AMGN, +3.5%) tried to lead the price-weighted index to the upside.
The health insurance and care provider joined with other high-priced stocks such as Goldman Sachs (GS, -1.6%) and Caterpillar (CAT, -4.3%), which at $900-plus and $600-plus account for its heaviest weightings, to drag the Dow back into the red after it set new all-time closing highs on Monday and Tuesday. UNH, the No. 7 Dow stock by weighting, closed at $341.81.
Track all markets on TradingViewMeanwhile, analyst Mike Yee assumed coverage of AMGN at UBS by raising the firm's rating on the biotech stock to Buy from Neutral (or Hold) and upping the 12-month target price to $380 from $317.
In a January 6 note, Yee cites potential earnings upside from Amgen's MariTide obesity drug and its lipoprotein therapy to address stroke and heart attack risk. The treatments are each in Phase III trials and "both of which should come to market and drive growth to the end of the decade."
Track all markets on TradingViewIs President Trump bad for beer sales?
Constellation Brands (STZ, -2.1%), facing a particular set of challenging circumstances among consumer staples stocks, is scheduled to report fiscal 2026 third-quarter earnings after Wednesday's closing bell.
Jefferies analyst Kaumil Gajrawala downgraded STZ from Buy to Hold and reduced his 12-month target price from $170 to $154 last month, noting that headwinds for Hispanic consumers due to the Trump administration's immigration policy "appear more prolonged than expected."
Track all markets on TradingViewResults of a recent immigration survey conducted by KFF and The New York Times suggest a delayed recovery, and the analyst lowered his fiscal year 2026 sales and earnings forecast.
"Immigration policy has led to a notable shift in behavioral patterns," Gajrawala writes, "with 41% of Hispanic respondents avoiding away-from-home activities." As Gajrawala explains, Hispanic consumers represent greater than 40% of sales for Constellation's beer portfolio.
Related content
- The Best Vanguard Bond Funds to Buy
- Best Stocks to Buy Now
- If You'd Put $1,000 Into Lowe's Stock 20 Years Ago, Here's What You'd Have Today
David DittmanInvesting EditorDavid Dittman is the former managing editor and chief investment strategist of Utility Forecaster, which was named one of "10 investment newsletters to read besides Buffett's" in 2015. A graduate of the University of California, San Diego, and the Villanova University School of Law, and a former stockbroker, David has been working in financial media for more than 20 years.
Latest-
Visa Stamps the Dow's 398-Point Slide: Stock Market Today
It's as clear as ever that President Donald Trump and his administration can't (or won't) keep their hands off financial markets.
-
State Tax Changes 2026: Is Your State Cutting (or Raising) Taxes This Year?
Tax Changes As a new year begins, taxpayers across the country are navigating a new round of state tax changes.
-
Who Said That? Match the US President to the Quotation
Who better to give advice on aging, retirement and finances than a U.S. president? Our short quiz will determine whether you're a history buff or buffoon.
-
Visa Stamps the Dow's 398-Point Slide: Stock Market Today
It's as clear as ever that President Donald Trump and his administration can't (or won't) keep their hands off financial markets.
-
The December CPI Report Is Out. Here's What It Means for the Fed's Next Move
The December CPI report came in lighter than expected, but housing costs remain an overhang.
-
The Paradox Between Money and Wealth: How Do You Find the Balance?
Wealth reflects a life organized around relationships, health, contribution and time — qualities that compound differently than money in a mutual fund.
-
Billed 12 Hours for a Few Seconds of Work: How AI Is Helping Law Firms Overcharge Clients
The ability of AI to reduce the time required for certain legal tasks is exposing the legal profession's reliance on the billable hour.
-
General Partner Stakes: Why Investors Are Buying Into the Business of Private Equity
GP stakes in asset management firms offer exposure to private markets and are no longer just for the wealthy. Find out why it looks like a good year to invest.
-
Stocks Climb Wall of Worry to Hit New Highs: Stock Market Today
The Trump administration's threats to Fed independence and bank profitability did little to stop the bulls on Monday.
-
How Worried Should Investors Be About a Jerome Powell Investigation?
The Justice Department served subpoenas on the Fed about a project to remodel the central bank's historic buildings.
-
5 Golden Rules We (Re)learned in 2025 About Investing
Some investing rules are timeless, and 2025 provided plenty of evidence demonstrating why they're useful. Here's a reminder of what we (re)learned.
